What Follow-Up for Early Gastric Cancer Patients Radically Treated?

Authors

  • Baiocchi Gian Luca Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
  • Guido Alberto Massimo Tiberio Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
  • Nazario Portolani Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
  • Arianna Coniglio Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
  • Federico Gheza Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
  • Sarah Molfino Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
  • Paolo Morgagni Department of General Surgery, Morgagni-Pierantoni Hospital, Forlì, Italy
  • Luca Saragoni Department of Pathology, G.B. Morgagni-L. Pierantoni Hospital, Forlì, Italy
  • Giovanni De Manzoni 1st Dept. of General Surgery, Borgo Trento Hospital, University of Verona, Verona, Italy
  • Stefano Maria Giulini Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

DOI:

https://doi.org/10.12974/2309-6160.2013.01.01.1

Keywords:

Early gastric cancer, surgery, follow-up, prognosis, CT scan, chemotherapy.

Abstract

Introduction: At the present state of knowledge, submitting patients radically operated for Early Gastric Cancer (EGC) to an imaging-based oncological follow-up doesn't improve survival. 

Materials and Methods: The present study was performed consulting the available Literature in PubMed and Embase. Manuscripts published in the period 1990-2012 were selected. A research inboard the Italian Research Group for Gastric Cancer (IRGGC) was also managed. 

Results: After radical resection for EGC, the 5-years risk of recurrence is 1.7%-6.8%; the risk of another tumor is 1.2%- 4.8%, so follow-up could be useless in almost 90% of cases. However, a lot of patients actually require to be followed over time after the intervention; furthermore, follow up is the only practice that should provide reliable data about time and mode of recurrence. Indeed, many high quality and high volume centers all around the world, and 100% of the 8 IRGGC Centers involved in this survey keep their patients currently under control. Looking for a rational approach, follow-up has to be especially considered for N+ patients, it has to last 5 years long and it must be based on CT with i.v. contrast medium injection alternating to abdominal ultrasonography. 

Conclusions: Despite the absence of a clear survival advantage, the practice of follow-up after radical gastrectomy for EGC should be supported. 

References

Cardoso R, Coburn NG, Seevaratnam R, Mahar A, Helyer L, Law C, Singh S. A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer 2012; 15(Suppl 1): S164-7. Epub 2012 Mar 2. Review. http://dx.doi.org/10.1007/s10120-012-0142-9

Whiting J, Sano T, Saka M, Fukagawa T, Katai H, Sasako M. Follow-up of gastric cancer: a review. Gastric Cancer. University Hospital Birmingham, Birmingham, UK 2006; 9(2): 74-81. http://dx.doi.org/10.1007/s10120-006-0360-0

Borie F, Plaisant N, Millat B, et al. French Associations for Surgical Research. Appropriate gastric resection with lymph node dissection for early gastric cancer. Ann Surg Oncol 2004; 11: 512-7. http://dx.doi.org/10.1245/ASO.2004.06.025

Tan IT, So BYJ. Value of intensive follow-up of patients after curative surgery for gastric carcinoma. J Surg Oncol 2007; 96: 503-6. http://dx.doi.org/10.1002/jso.20823

Mikani K, Yamashita Y, Maekawa T, Shinohara T, Yamauchi Y, Hoshino S, et al. Surveillance program for recurrence after curative gastric cancer surgery. Chir Gastroenterol 2007; 23: 392-8. http://dx.doi.org/10.1159/000109243

Bennett JJ, Gonen M, D’Angelica M, Jaques DP, Brennan MF, Coit DG. Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg 2005; 201(4): 503-510. http://dx.doi.org/10.1016/j.jamcollsurg.2005.05.033

Bohner H, Zimmer T, Hopfenmuller W, Berger G, Buhr H-J. Detection and prognosis of recurrent gastric cancer—is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology 2000; 47: 1489-94.

Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol 2003; 10(8): 898-902. http://dx.doi.org/10.1245/ASO.2003.12.009

Kim JH, Jang YJ, Park SS, Park SH, Mok YJ. Benefit of postoperative surveillance for recurrence after curative resection for gastric cancer. J Gastrointest Surg 2010; 14(6): 969-76. Epub 2010 Apr 22. http://dx.doi.org/10.1007/s11605-010-1200-4

Eom BW, Ryu KW, Lee JH, Choi IJ, Kook MC, Cho SJ, et al. Oncologic Effectiveness of Regular Follow-up to Detect Recurrence After Curative Resection of Gastric Cancer. Ann Surg Oncol 2010 Nov 2.

[Epub ahead of print].

Baiocchi GL, Tiberio G, Minicozzi A, et al. A multicentric western analysis of prognostic factors in advanced, nodenegative gastric cancer patients. Ann Surg 2010; 252: 70-3. http://dx.doi.org/10.1097/SLA.0b013e3181e4585e

Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, et al. Significance of long-term follow-up of early gastric cancer. Ann Surg Oncol 2006; 13(3): 363-9. Epub 2006 Jan 30. http://dx.doi.org/10.1245/ASO.2006.03.061

Huang B, Wang Z, Xing C, Sun Z, Zhao B, Xu H. Long-term survival results and prognostic factors of early gastric cancer. Exp Ther Med 2011; 2(6): 1059-1064. Epub 2011 Jul 26.

Lai JF, Kim S, Kim K, Li C, Oh SJ, Hyung WJ, et al. Prediction of recurrence of early gastric cancer after curative resection. Ann Surg Oncol 2009; 16(7): 1896-902. Epub 2009 May 12. http://dx.doi.org/10.1245/s10434-009-0473-x

Viste A, Rygh AB, Søreide O. Cancer of the stomach--is a follow-up program of any importance for the patient? Clin Oncol 1984; 10(4): 325-32.

Hur H, Song KY, Park CH, Jeon HM. Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea. Ann Surg Oncol 2010; 17(1): 54-64. Epub 2009 Sep 24. http://dx.doi.org/10.1245/s10434-009-0676-1

Marrelli D, Caruso S, Roviello F. Follow-up and treatment of recurrence. In: de Manzoni G, Roviello F, Siquini W, Eds. Surgery in the Multimodal Management of Gastric Cancer, Springer-Verlag Italia 2012.

Bang YJ, Cutsem EV, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010; 376(9741): 687-97. http://dx.doi.org/10.1016/S0140-6736(10)61121-X

Allum WH, Griffin SM, Watson A, Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut 2002; 50(Suppl 5): v1-23.

Ikeda Y, Saku M, Kishihara F, Maehara Y. Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 2005; 92(2): 235-9. http://dx.doi.org/10.1002/bjs.4758

Youn HG, An JY, Choi MG, Noh JH, Sohn TS, Kim S. Recurrence after curative resection of early gastric cancer. Ann Surg Oncol 2010; 17(2): 448-54. Epub 2009 Nov 11. http://dx.doi.org/10.1245/s10434-009-0772-2

Lee SY, Lee JH, Hwang NC, et al. The role of follow-up endoscopy after total gastrectomy for gastric cancer. Eur J Surg Oncol 2005; 31: 265-9. http://dx.doi.org/10.1016/j.ejso.2004.11.018

Yamamoto M, Yamanaka T, Baba H, Kakeji Y, Maehara Y. The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinoma. J Surg Oncol 2008; 97(3): 231-5. http://dx.doi.org/10.1002/jso.20946

Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer 1993; 72: 3174-8. http://dx.doi.org/10.1002/1097- 0142(19931201)72:11<3174::AIDCNCR2820721107> 3.0.CO;2-H

Jackson C, Cunningham D, Oliveira J, On behalf of the ESMO Guidelines Working Group. Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and followup. Ann Oncol 2009; 20(Suppl 4): iv34-6. http://dx.doi.org/10.1093/annonc/mdp122

Nashimoto A, Yabusaki H, Nakagawa S.

[Proper follow-up schedule after curative gastric surgery]. Gan To Kagaku Ryoho 2009; 36(9): 1402-7.

Yoo SY, Kim KW, Han JK, Kim AY, Lee HJ, Choi BI. Helical CT of postoperative patients with gastric carcinoma: value in evaluating surgical complications and tumor recurrence. Abdom Imaging 2003; 28(5): 617-23. http://dx.doi.org/10.1007/s00261-003-0007-0

Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Wu H. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. World J Gastroenterol 2008; 14(29): 4627-32. http://dx.doi.org/10.3748/wjg.14.4627

Morgagni P, Marfisi C, Gardini A, et al. Subtotal Gastrectomy as Treatment for Distal Multifocal Early Gastric Cancer. J Gastrointest Surg 2009; 13: 2239-44. http://dx.doi.org/10.1007/s11605-009-0971-y

Qui MZ, Lin JZ, Wang ZQ, Pan ZZ, Luo HY, Li YH, et al. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Int J Biol Markers 2009; 24(4): 258-64.

Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, et al. Tumor Marker Committee. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 2003; 6(3): 142-5. http://dx.doi.org/10.1007/s10120-003-0240-9

Marrelli D, Pinto

Downloads

Published

2013-04-04

How to Cite

Luca, B. G., Massimo Tiberio, G. A. ., Portolani, N., Coniglio, A., Gheza, F., Molfino, S., Morgagni, P., Saragoni, L., De Manzoni, G., & Giulini, S. M. (2013). What Follow-Up for Early Gastric Cancer Patients Radically Treated?. Global Journal of Oncologists, 1(1), 1–5. https://doi.org/10.12974/2309-6160.2013.01.01.1

Issue

Vol. 1 No. 1 (2013)

Section

Articles